pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

9,535 catalysts · 3,404 8k filing · 2,029 grant · 1,000 device adverse event · 897 approval · 659 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-17: 0 catalysts2026-08-18: 0 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-30×clear all
type
  • 8k filing3,404
  • grant2,029
  • device adverse event1,000
  • approval897
  • device 510k659
  • earnings584
device pma
503
  • device recall211
  • phase 2 completion172
  • recall167
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Mar 23, 2026

    50
    ›Mar 25, 2026device 510k147d agoSpinepoint, LLC — Flex-Z™ Cervical Cage (510k cleared)

    Product code: ODP. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 25, 2026device 510k147d agoMevion Medical Systems, Inc. — S250-FIT Proton Beam Radiation Therapy Device (S250-FIT) (510k cleared)MERIT MEDICAL SYSTEMS INC

    Product code: LHN. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 25, 2026device 510k147d agoBausch and Lomb, Incorporated — Stellaris Elite™ vision enhancement system (BL11145, BL14455, BL15455, SE14565, SE15565, SE14565E, SE15565E) (510k cleared)

    Product code: HQC. Advisory committee: Ophthalmic. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 25, 2026device pma147d agoLenstec, Inc. — ClearView 3 IOL (PMA supplement)

    Supplement type: Real-Time Process. Product code: MFK. Advisory committee: OP. Decision: APPR

    full page →fda device pma ↗
    ›Mar 25, 2026device pma147d agoABBOTT MEDICAL — CardioMEMS™ HF System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MOM. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 25, 2026device pma147d agoBoston Scientific Corp — WATCHMAN LEFT ATRIAL APPENDAGE (LAA) CLOSURE TECHNOLOGY (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: Normal 180 Day Track No User Fee. Product code: NGV. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Mar 25, 2026device pma147d agoABBOTT MEDICAL — HeartMate 3™ Left Ventricular Assist System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: DSQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 25, 2026device pma147d agoMedtronic Vascular — Onyx Frontier Zotarolimus Eluting Coronary Stent System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NIQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 25, 2026device pma147d agoMedtronic, Inc. — Symplicity Spyral™ Renal Denervation Catheter (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: QYI. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 25, 2026device pma147d agoCook Ireland, Ltd. — Zilver® PTX® Drug-Eluting Peripheral Stent (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NIU. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 25, 2026grant147d agoMASSACHUSETTS GENERAL HOSPITAL — Characterizing intracortical feedforward and feedback sensory processes in ASDMassachusetts General Hospital

    MH grant. $824,728. PI: Jyrki Ahveninen

    full page →nih reporter ↗
    ›Mar 25, 2026grant147d agoUNIVERSITY OF TEXAS HLTH SCIENCE CENTER — Development of first-in-class AAK1 PROTACs for ovarian cancer

    CA grant. $593,338. PI: Lingtao Jin

    full page →nih reporter ↗
    ›Mar 25, 2026grant147d agoSTANFORD UNIVERSITY — Advancing Personalized Cardiac Organoids - Converging In Vitro, In Chemico, a...Stanford University

    TR grant. $3,091,157. PI: Afshin Beheshti

    full page →nih reporter ↗
    ›Mar 25, 2026grant147d agoMASSACHUSETTS INSTITUTE OF TECHNOLOGY — A Platform for Arene Activation via Machine Learning and Small Molecule Catal...

    GM grant. $74,632. PI: Andria Pace

    full page →nih reporter ↗
    ›Mar 25, 2026grant147d agoMEDICAL UNIVERSITY OF SOUTH CAROLINA — RESP-FIT: A Respiratory Muscle Strength Training Intervention for COPD

    NR grant. $1,778,418. PI: Sarah N. Miller

    full page →nih reporter ↗
    ›Mar 25, 2026grant147d agoWASHINGTON UNIVERSITY — Neural Circuits in Preoptic Hypothalamus Regulating Energy Expenditure and Me...

    DK grant. $720,353. PI: Aaron J Norris

    full page →nih reporter ↗
    ›Mar 25, 2026grant147d agoJOHNS HOPKINS UNIVERSITY — Adapting and testing an evidence based digitally delivered healthy relationsh...Johns Hopkins University

    NR grant. $1,804,481. PI: Teresa Brockie

    full page →nih reporter ↗
    ›Mar 25, 2026grant147d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Ghrelin receptor and striosomal interactions in stress-induced decision-makingDutch Heart Foundation

    MH grant. $827,879. PI: Alexander Friedman

    full page →nih reporter ↗
    ›Mar 26, 2026approval146d agoCLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

    full page →CLEOCIN →fda approvals ↗
    ›Mar 26, 2026approval146d agoBKEMV (ECULIZUMAB-AEEB) — FDA approvaleculizumab biosimilar

    Sponsor: AMGEN INC. Form: INJECTABLE. Route: INJECTION

    full page →eculizumab biosimilar →fda approvals ↗
    ›Mar 26, 2026approval146d agoCLEOCIN HYDROCHLORIDE (CLINDAMYCIN HYDROCHLORIDE) — FDA approvalclindamycin hydrochloride

    Sponsor: PFIZER. Form: CAPSULE. Route: ORAL

    full page →clindamycin hydrochloride →fda approvals ↗
    ›Mar 26, 2026approval146d agoNOREPINEPHRINE BITARTRATE IN 5% DEXTROSE (NOREPINEPHRINE BITARTRATE) — FDA approvalNOREPINEPHRINE BITARTRATE

    Sponsor: SAGENT. Form: SOLUTION. Route: INTRAVENOUS

    full page →NOREPINEPHRINE BITARTRATE →fda approvals ↗
    ›Mar 26, 2026approval146d agoMEKINIST (TRAMETINIB) — FDA approvalSpexotras

    Sponsor: NOVARTIS. Form: SOLUTION. Route: ORAL

    full page →Spexotras →fda approvals ↗
    ›Mar 26, 2026approval146d agoTAFINLAR (DABRAFENIB MESYLATE) — FDA approvaldabrafenib mesylate ODT

    Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

    full page →dabrafenib mesylate ODT →fda approvals ↗
    ›Mar 26, 2026approval146d agoMEKINIST (TRAMETINIB DIMETHYL SULFOXIDE) — FDA approvalSpexotras

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →Spexotras →fda approvals ↗
    ›Mar 26, 2026approval146d agoCLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approvalCLEOCIN

    Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION

    full page →CLEOCIN →fda approvals ↗
    ›Mar 26, 2026approval146d agoKADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvaltrastuzumab emtansine

    Sponsor: GENENTECH. Form: VIAL. Route: SINGLE-USE

    full page →trastuzumab emtansine →fda approvals ↗
    ›Mar 26, 2026approval146d agoAWIQLI FLEXTOUCH (INSULIN ICODEC) — FDA approvalinsulin icodec

    Sponsor: NOVO NORDISK INC. Form: INJECTION. Route: SOLUTION

    full page →insulin icodec →fda approvals ↗
    ›Mar 26, 2026approval146d agoLABETALOL HYDROCHLORIDE — FDA approvalLABETALOL HYDROCHLORIDE

    Sponsor: HERITAGE PHARMA. Form: TABLET. Route: ORAL

    full page →LABETALOL HYDROCHLORIDE →fda approvals ↗
    ›Mar 26, 2026approval146d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: ALEMBIC. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Mar 26, 2026approval146d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: ALEMBIC. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Mar 26, 2026approval146d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

    Sponsor: ALEMBIC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 26, 2026approval146d agoNEFFY (EPINEPHRINE) — FDA approvalInternational Medication Systems Ltd

    Sponsor: ARS PHARMS OPERATION. Form: SPRAY. Route: NASAL

    full page →fda approvals ↗
    ›Mar 26, 2026approval146d agoNEFFY (EPINEPHRINE) — FDA approvalInternational Medication Systems Ltd

    Sponsor: ARS PHARMS OPERATION. Form: SPRAY. Route: NASAL

    full page →fda approvals ↗
    ›Mar 26, 2026approval146d agoTAFINLAR (DABRAFENIB MESYLATE) — FDA approvaldabrafenib mesylate ODT

    Sponsor: NOVARTIS. Form: CAPSULE. Route: ORAL

    full page →dabrafenib mesylate ODT →fda approvals ↗
    ›Mar 26, 2026device 510k146d agoLunit, Inc. — Lunit INSIGHT DBT (V1.2) (510k cleared)

    Product code: QDQ. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k146d agoMedtronic Navigation, Inc. — Stealth AXiS Cranial clinical application (510k cleared)

    Product code: HAW. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k146d agoVizaramed, Inc. — Multiflex Steerable Sheath 17.5F (510k cleared)

    Product code: DYB. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k146d agoSurgify Medical OY — Surgify Halo (54.085.SHD.U1); Surgify Halo (54.140.SHD. U1); Surgify Halo (54.070.NVG.U1); Surgify Halo (54.125.NVG.U1); Surgify Halo (54.000.SEE.U1); Surgify Halo (40.070.NVG.U1); Surgify Halo (40.125.NVG.U1); Surgify Halo (40.000.SEE.U1); Surgify Halo (30.070.NVG.U2); Surgify Halo (30.125.NVG.U2); Surgify Halo (30.000.SEE.U2) (510k cleared)

    Product code: HBE. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k146d agoBIOMERIEUX — VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL) (510k cleared)

    Product code: LON. Advisory committee: Microbiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k146d agoBlue Belt Technologies, Inc. — REAL INTELLIGENCE™ CORI™ (510k cleared)BETA Technologies, Inc.

    Product code: OLO. Advisory committee: Neurology. Type: Special

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k146d agoDevilbiss Healthcare, LLC — DeVilbiss 5 Liter Oxygen Concentrator (555) (510k cleared)

    Product code: CAW. Advisory committee: Anesthesiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k146d agoShenzhen Urion Technology Co., Ltd. — Automatic Electronic Blood Pressure Monitor (U90B series models including ( U90B,U90B Pro,U90B Plus,U90B Ultra,U90C,U90C Pro,U90C Plus,U90C Ultra).) (510k cleared)Fortior Technology (Shenzhen) Co., Ltd./ADR

    Product code: DXN. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k146d agoAirs Medical, Inc. — SwiftMR (510k cleared)AVITA Medical, Inc.

    Product code: QIH. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device 510k146d agoRestore Robotics — Robotic Surgical Instruments - Permanent Cautery Hook (470183); Robotic Surgical Instruments - Permanent Cautery Spatula (470184) (510k cleared)

    Product code: QSM. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Mar 26, 2026device pma146d agoMedinol, Ltd. — EluNIR™ Ridaforolimus Eluting Coronary Stent System (PMA supplement)IGC Pharma, Inc.

    Supplement type: 30-Day Notice. Product code: NIQ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Mar 26, 2026device pma146d agoMedtronic Neuromodulation — Altaviva™ (PMA supplement)

    Supplement type: Normal 180 Day Track No User Fee. Product code: QPT. Advisory committee: GU. Decision: APPR

    full page →fda device pma ↗
    ›Mar 26, 2026device pma146d agoBolton Medical, Inc. — TREO® Abdominal Stent-Graft System (PMA supplement)

    Supplement type: Normal 180 Day Track. Product code: MIH. Advisory committee: CV. Decision: APPR

    full page →fda device pma ↗
    ›Mar 26, 2026grant146d agoMEDICAL UNIVERSITY OF SOUTH CAROLINA — Data Analytics Training And Professional Development (DATA-Pro) for Behaviora...

    CA grant. $215,976. PI: Kalyani Sonawane

    full page →nih reporter ↗
    ›Mar 26, 2026grant146d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — The Impact of Bile Salt Hydrolase on Intestinal T Cells in ColitisUniversity of California San Diego

    DK grant. $43,313. PI: Elizabeth A Brown

    full page →nih reporter ↗
    ← prev
    page 62 of 191
    next →
    $MDT92.09+1.64%
    $PFE27.25+1.41%
    $AMGN425.28+1.41%
    $PFE27.25+1.41%
    $NVS154.55+1.70%
    $NVS154.55+1.70%
    $NVS154.55+1.70%
    $MMSI89.26-0.52%
    $BSX50.47-1.87%
    $NVO45.71+1.85%
    $PFE27.25+1.41%
    $BETA16.10+2.09%
    $FRTRY
    $RCEL9.8500+24.68%
    $IGC0.2670+0.41%
    $NVS154.55+1.70%